Physician profile
Erin M Smith
NPI 1639614431
$2,747.50
in general payments reported to CMS, 2019-2025
20 companies · $822 in 2025
The $822 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.63 · 2022: $195 · 2023: $874 · 2024: $817 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,513.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $846.79 | 2022-2025 | |
| Pfizer INC. | $446.57 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $306.82 | 2023-2025 | Brilinta, Farxiga |
| Merck Sharp & Dohme LLC | $178.50 | 2022-2025 | Verquvo |
| Abbott Laboratories | $166.38 | 2023 | Cardiomems |
| Amgen INC. | $139.89 | 2023-2025 | Repatha, Repatha |
| Novo Nordisk INC | $111.88 | 2024-2025 | Wegovy, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $91.19 | 2024-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $89.98 | 2022-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.80 | 2022-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $58.88 | 2025 | Eliquis, Camzyos |
| Cvrx, INC. | $57.27 | 2024 | Barostim Neo System |
| Atricure, INC. | $50.17 | 2025 | Atriclip Laa Exclusion System |
| Orthofix Medical, INC. | $24.57 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $20.11 | 2024 | Arcalyst |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $18.75 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.72 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $15.18 | 2023 | Inpefa |
| Endo Pharmaceuticals INC. | $15.06 | 2021 | |
| Boston Scientific Corporation | $13.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.